Categories
Cancer Care (474)
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (288)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (21)
Anti-inflammatory (13)
Antidepressants (9)
Ascorbic Acid (13)
autoantibodies (10)
autophagy (48)
Breast Cancer (30)
Cancer (69)
Cancer Stem Cells (11)
Chemotherapy (12)
Colon Cancer (11)
Corticosteroids (9)
COVID-19 (330)
COVID-19 Vaccines (8)
Curcumin (14)
Cytokines (13)
Depression (12)
Diabetes (14)
Famotidine (14)
Hydroxychloroquine (15)
Hyperbaric Oxygen Therapy (9)
Inflammation (15)
intermittent fasting (14)
ivermectin (53)
long COVID (21)
Macrophages (18)
Mast Cells (8)
Melatonin (23)
Mitochondria (14)
Myeloid Cells (10)
Pneumonia (9)
quercetin (15)
resveratrol (11)
SARS-CoV-2 (83)
Sepsis (22)
spermidine (11)
Spike Protein (12)
Thiamine (11)
Thrombosis (9)
Tinnitus (12)
Tumor (41)
Vitamin C (30)
Vitamin D (29)
Zinc (12)
Auhtors: Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC PMID: 26906526 DOI: 10.1016/S1470-2045(15)00558-6 Abstract Background: Patients with advanced cancer frequently experience anorexia and cachexia, which are associated with reduced food intake, altered body composition, and decreased functionality. We assessed anamorelin, a novel ghrelin-receptor agonist, on cachexia in patients with [...]
Categories: Cancer Care
Tags: Anamorelin, Cancer Cachexia, Lung Cancer
